ATOS

Atossa Therapeutics Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth↓ 1/10
  • Momentum↓ 0/10
Atossa Therapeutics sales and earnings growth
ATOS Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -9.09%
  • FCF Y/Y↓ -34.35%
Atossa Therapeutics gross and profit margin trends
ATOS Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↑ 5857.40%
Atossa Therapeutics net debt vs free cash flow
ATOS Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Atossa Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗